Recombinant human interleukin-2
| Recombinant human interleukin-2 | |
|---|---|
| Term | Recombinant human interleukin-2 |
| Short definition | recombinant human interleukin-2 - (pronounced) (ree-KOM-bih-nunt HYOO-mun inter-ter-LOO-kin. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
recombinant human interleukin-2 - (pronounced) (ree-KOM-bih-nunt HYOO-mun inter-ter-LOO-kin. . . ) drug used to treat adults with melanoma or renal cell carcinoma (a type of kidney cancer) that has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Recombinant human interleukin-2 is a laboratory-made form of interleukin-2. Recombinant human interleukin-2 increases the activity and growth of white blood cells called T lymphocytes and B lymphocytes, which may help the immune system kill cancer cells. Recombinant human interleukin-2 is a type of cytokine and a type of immunomodulating agent. Also called aldesleukin and proleukin
External links
- Medical encyclopedia article on Recombinant human interleukin-2
- Wikipedia's article - Recombinant human interleukin-2
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski